close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

11.70 +0.58 (+5.22%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vir Biotechnology, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
Brii Biosciences, Vir Biotech, VBI Vaccines Start Combination Therapy Hepatitis B Study ↗
Privately-held Brii Biosciences, Vir Biotechnology Inc (NASDAQ: VIR), and VBI Vaccines Inc (NASDAQ: VBIV) have dosed the first patient... 
Via Benzinga
News headline image
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
From Brii Biosciences and Vir Biotechnology, Inc. and VBI Vaccines Inc.
Via Business Wire
News headline image
Could Vir Biotechnology Be a Millionaire Maker Stock? ↗
Vir is developing treatments in billion-dollar markets. 
Via The Motley Fool
News headline image
Which Stock Is Likely to Be the Biggest Winner: Lilly, Vir, or GlaxoSmithKline? ↗
One of the three clearly has the most upside potential. 
Via The Motley Fool
News headline image
Vir Biotechnology vs. Sorrento Therapeutics: The Wisdom of Crowds Says... ↗
Which stock has more potential for growth over the next year? Let's look to the stars for an answer. 
Via The Motley Fool
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.